Doxorubicin pathways: pharmacodynamics and adverse effects.
Article Details
- CitationCopy to clipboard
Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB
Doxorubicin pathways: pharmacodynamics and adverse effects.
Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56.
- PubMed ID
- 21048526 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs